Mr. Gregory Crawford reports

QUIPT HOME MEDICAL ANNOUNCES VOTING RESULTS FROM SPECIAL MEETING OF SHAREHOLDERS

Quipt Home Medical Corp. has released the voting results from its special meeting of holders of common shares of the company, held on March 3, 2026, in Sarasota, Fla. The shareholders voted to approve the special resolution approving the plan of arrangement under the Business Corporations Act (British Columbia), involving, among other things, the acquisition by affiliates of Kingswood Capital Management LP and Forager Capital Management LLC of all of the issued and outstanding shares for cash consideration of $3.65 (U.S.) per share.

The arrangement resolution required approval of: (i) at least 66-2/3rd per cent of the votes cast by shareholders, present in person or represented by proxy at the meeting; and (ii) in accordance with Multilateral Instrument 61-101, Protection of Minority Security Holders in Special Transactions, a simple majority of votes cast by the shareholders, present in person or represented by proxy and entitled to vote at the meeting, excluding the votes in respect of shares cast by any interested party, any related party of an interested party or any joint actor (as such terms are defined in MI 61-101). Shareholders holding 29,672,136 shares, representing approximately 66.93 per cent of the outstanding shares, were represented in person or by proxy at the meeting. The arrangement resolution was approved by: (i) shareholders holding 98.9 per cent of the shares voted; and (ii) shareholders holding 98.7 per cent of the shares voted, after excluding the votes cast by the shareholders whose votes were required to be excluded in determining minority approval under MI 61-101.

The company is scheduled to seek a final order of the Supreme Court of British Columbia approving the arrangement on March 5, 2026. Assuming all other terms and conditions, including applicable stock exchange and regulatory approvals, to the arrangement are satisfied, it is expected that the arrangement will be completed in the near term. Further information about the arrangement can be found in the company's definitive proxy statement and management information circular dated Jan. 23, 2026, for the meeting, which is available under the company's profile on SEDAR+ and on the company's website, and has been filed with the U.S. Securities and Exchange Commission (SEC) on EDGAR.

A Form 8-K in respect of the voting results has been filed with the SEC on EDGAR and on SEDAR+ under the company's issuer profile.

About Quipt Home Medical Corp.

The company provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States health care market. It seeks to continue to expand its offerings to include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. The primary business objective of the company is to create shareholder value by offering a broader range of services to patients in need of in-home monitoring and chronic disease management. The company's organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient's services and making life easier for the patient.

We seek Safe Harbor.